Pretreatment With DNA-damaging Agents Permits Selective Killing of Checkpoint-Deficient Cells by Microtubule-Active Drugs

Journal of Clinical Investigation - United States
doi 10.1172/jci8625
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Sensitization of Cancer Cells to DNA Damaging Agents by Imidazolines

English

Activation of ATM by DNA Damaging Agents

2004English

Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Induction of RNA-binding Proteins in Mammalian Cells by DNA-damaging Agents.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Combating Resistance to DNA Damaging Agents

Oncoscience
Cancer ResearchOncology
2018English

Pharmacological Inhibition of EZH2 Combined With DNA‑damaging Agents Interferes With the DNA Damage Response in MM Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Methods for Detecting DNA Damaging Agents in Humans

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1989English

Hyperactive End Joining Repair Mediates Resistance to DNA Damaging Therapy in P53-Deficient Cells

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy